By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Coronado Biosciences 

4365 Executive Drive
Suite 1500
San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a


Start Up

Company News
Coronado Biosciences (CNDO) Forms New Subsidiary, Diavax Biosciences, To Develop Novel Immunotherapies For Cytomegalovirus 4/2/2015 7:14:26 AM
Coronado Biosciences (CNDO) Announces Exclusive Licensing Agreement With Neupharma To Develop And Commercialize Novel Covalent 3rd Generation EGFR Inhibitors 3/19/2015 7:38:45 AM
New Company Mustang Therapeutics Formed by Coronado Biosciences (CNDO), City of Hope 3/19/2015 7:29:32 AM
Coronado Biosciences (CNDO) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 201 3/16/2015 7:53:29 AM
Coronado Biosciences (CNDO) Forms New Subsidiary, Checkpoint Therapeutics, To Develop Novel Immuno-Oncology Antibodies 3/4/2015 7:11:28 AM
Coronado Biosciences (CNDO) Closes $10 Million Private Placement Financing 3/3/2015 7:10:55 AM
Coronado Biosciences (CNDO) In-Licenses IV Tramadol, A Phase III Ready Asset, From Revogenex Ireland Ltd. 2/18/2015 7:40:51 AM
Coronado Biosciences (CNDO) Reports On Separation Of CB Pharma Acquisition Corp. Securities 1/6/2015 7:45:35 AM
Coronado Biosciences (CNDO) Announces Pricing Of Initial Public Offering Of CB Pharma Acquisition Corp. 12/15/2014 8:04:11 AM
Coronado Biosciences (CNDO) Raises $3.5 Million Through The Private Placement Of Restricted Common Stock 11/7/2014 7:42:46 AM